This protocol describes using cultured Aorta-Gonad-Mesonephros for expression analyses, colony-forming units in the culture and spleen, and long-term reconstitution to determine the effect of regulatory factors and signaling pathways on hematopoietic stem cell development. This has been demonstrated as an effective system for studying hematopoietic stem cell biology and function.
Cite this ArticleCopy Citation | Download Citations | Reprints and Permissions
Lv, J., Liu, F. Application of Aorta-gonad-mesonephros Explant Culture System in Developmental Hematopoiesis. J. Vis. Exp. (129), e56557, doi:10.3791/56557 (2017).
Translate text to:
The limitation of using mouse embryos for hematopoiesis studies is the added inconvenience in operations, which is largely due to the intrauterine development of the embryo. Although genetic data from knockout (KO) mice are convincing, it is not realistic to generate KO mice for all genes as needed. In addition, performing in vivo rescue experiments to consolidate the data obtained from KO mice is not convenient. To overcome these limitations, the Aorta-Gonad-Mesonephros (AGM) explant culture was developed as an appropriate system to study hematopoietic stem cell (HSC) development. Especially for rescue experiments, it can be used to recover the impaired hematopoiesis in KO mice. By adding the appropriate chemicals into the medium, the impaired signaling can be reactivated or up-regulated pathways can be inhibited. With the use of this method, many experiments can be performed to identify the critical regulators of HSC development, including HSC related gene expression at mRNA and protein levels, colony formation ability, and reconstitution capacity. This series of experiments would be helpful in defining the underlying mechanisms essential for HSC development in mammals.
Hematopoietic stem cells (HSCs) are tissue-specific adult stem cells that possess multilineage potential including erythroid, myeloid, and lymphoid cells as well as the ability to self-renew. Recent studies have shown that the earliest HSCs arose from a specialized endothelial population, known as hemogenic endothelium (HE), through the endothelial to hematopoietic transition (EHT) at the ventral wall of dorsal aorta1,2,3,4. Once formed in the aorta-gonad-mesonephros (AGM) region from embryonic (E) 10.5 to E12.5 in the mouse embryo, HSCs will migrate into the fetal liver for expansion and finally colonize the bone marrow to maintain adult hematopoiesis throughout an individual's life5,6. Although this has been studied for many years, the underlying mechanisms of HSC emergence and development remain incompletely understood.
Unlike in vitro fertilization and development of zebrafish embryos, intrauterine development of mouse embryos makes the study of definitive hematopoiesis during embryogenesis much more inconvenient. Although genetic experiments using knockout (KO) mice are commonly utilized, the lack of certain KO mice also limits their use in the hematopoietic research field. In addition, in vivo rescue experiments are not easily performed in KO mice. Since 1996, the AGM explant culture has been developed for hematopoietic studies by the pioneers in the field7. With the help of this culture system, ventral tissues of the AGM region have been identified to promote HSC activity, while dorsal tissues exert an opposite effect8,9. The AGM explant culture system has also been applied to determine the roles of Serotonin, Mpl, SCF, BMP, and Hedgehog signaling in HSC development10,11,12,13,14. Importantly, it is also a popular method used to rescue hematopoietic defects in mutant embryos13,15.
All the procedures including animal subjects have been approved by the Ethical Review Committee in the Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
1. Material Preparation
- Sterilize the 0.65 µm filters with ultraviolet rays produced under the ultraviolet ray lamp on the clean bench for 4 h and turn the filters over after the 2 h mark.
NOTE: When working with UV light, wear appropriate protection.
- Sterilize the stainless steel meshes with the autoclave sterilizer at 121 °C for 30 mins.
NOTE: A certain height of stainless steel mesh is needed to support the filters at the air-liquid interface and this can be realized with the wire on the steel mesh (Figure 1A).
- Dilute Fluoxetine to a final concentration of 10 µM into the M5300 long-term culture medium and mix evenly.
NOTE: For a six-well plate, 2 mL M5300 long-term culture medium is appropriate for each well. Hydrocortisone at 10-6 M can be selectively diluted into the medium.
- Transfer the medium supplemented with Fluoxetine at 10 µM into six-well plates or dishes and put the sterilized stainless steel meshes into the medium.
- Wash the 0.65 µm filters with boiling water two times for 3 mins each time in the glass cell culture dish for sterilization. After each washing, put the filters into phosphate buffered saline (PBS) for 2 mins and place the wet filters onto the stainless steel meshes standing at the air-liquid interface as shown in Figure 1A [schematic in the center].
NOTE: Boiling water can be generated with the autoclave sterilizer to achieve the asepsis and equipment should be taken out of autoclave sterilizer in a timely fashion to avoid a decrease in temperature.
2. AGM Explant Culture
- Carefully separate the AGM regions from the embryos at E10.5 or E11 with forceps.
- Strip the uteruses from pregnant mice with the dissecting scissors and separate the embryos from the uteruses.
- Wipe off the yolk sac, umbilical cord, and viscera from the embryo body.
- Carefully remove the dorsal nerve tissues and surrounding muscular tissues.
- Cut off the tissues with the forceps at the site of anterior and hind limbs and separate the AGM region from the embryo body. Figures 1B-C show the schematic representation and morphology of dissected AGM.
- Explant the dissected AGMs separately onto the filters at the air-liquid interface (Figure 1A) and culture in 5% CO2 at 37 °C for 2 - 3 days.
NOTE: Do not place the dissected AGM onto the wire of the steel mesh and make sure the filters are at the air-liquid interface during culture. Besides the AGM, yolk sac and fetal liver can also be cultured with this system7.
3. Expression Analyses
- mRNA level
- Collect the cultured AGMs into 1 mL PBS and centrifuge at 4 °C, 310 x g for 6 min.
- After removing the supernatant, total RNA is extracted from the collected AGMs with a monophasic solution of phenol, according to the manufacturer's instructions.
- Total RNA (2 µg) is then reverse transcribed using M-MLV reverse transcriptase to obtain cDNA as the template. The quantitative real-time PCR assays are performed with SYBR Green and Gapdh is used as the internal control.
- Protein level
- Collect the cultured AGM as described above in step 3.1.1.
- Prepare the protein from the cultured AGM with the cell lysis buffer (10 mM Tris-HCl, 10 mM NaCl, and 0.5% NP-40) containing protease inhibitor and use for western blotting to detect the protein level as previously described13.
4. Colony-Forming Units in the Culture (CFU-C) Assay
- After culturing for 2 - 3 days, collect the AGM regions into 1 mL phosphate buffered saline (PBS) and centrifuge at 4 °C, 310 x g for 6 mins and dissociate with 200 µL collagenase (0.1% in PBS) at 37 °C.
NOTE: The time needed for collagenase to generate single cell-suspensions is about 20 mins. Shaking the tube containing AGM every 5 mins can accelerate the digestion process. 200 µL 0.1% collagenase is used for each AGM and 200 µL 10% serum is used to stop the reaction.
- Culture single cell-suspensions in M3434 medium in ultra-low attachment 24-well plates.
NOTE: To avoid contamination, Penicillin-Streptomycin solution can be selectively added into the medium. Because the M3434 medium is viscous, a 1.0 cc syringe without a needle is used to mix the cells and medium.
- After 7 - 10 days culturing at 37 °C in 5% CO2, the number for each type of colonies including Burst forming unit--erythroid (BFU-E), CFU-granulo-monocyte (CFU-GM) and CFU-granulocyte, erythrocyte, macrophage, megakaryocyte (CFU-GEMM) are distinguished based on the morphology and scored with an inverted microscope (Figure 2C).
5. In Vivo Transplantation Assay
- Colony-forming units-spleen (CFU-S) assay
- After 2 - 3 days of explant culturing, collect the AGMs and prepare single cell-suspensions by incubating with 200 µL collagenase (0.1% in PBS) for 20 min.
- Perform lethal irradiation (9 Gy of X-rays) of 8- to 10-week old male C57BL/6 mice 4 - 5 h before cell injection.
- Put the irradiated mouse into a restrainer to restrict its activity.
- Wipe the tail using a cotton swab steeped in 75% alcohol to promote vasodilatation of the vein.
- Inject 0.5 embryo equivalent (ee) or 1 ee single cell-suspensions of AGM intravenously into the tail vein of irradiated mouse with a 1.0 cc syringe.
NOTE: Cells are suspended with PBS and 0.5 mL PBS per recipient is a suitable volume. A needle of 25 gauge or 26 gauge size is used for injection with a 1.0 cc syringe. No air can be introduced into the syringe. Press the injection site with an antiseptic swab to stop bleeding.
- Eleven days post transplantation, collect and fix the spleens of the recipient mice in Bouin's solution (15 mL 1.22% Picric acid saturated aqueous solution, 2 mL 40% methanol and 1 mL acetic acid) for 1 - 2 days and wash with 80% alcohol for another 1 - 2 days. Count the visible colonies in the spleen macroscopically and determine the number of colonies per ee.
NOTE: Bouin's fixative, wear appropriate protection.
- Long-term transplantation assay
- After 2 - 3 days explant culturing, collect the AGMs and prepare single cell-suspensions by incubating with 200 µL collagenase (0.1% in PBS) for 20 min.
- Perform lethal irradiation (9 Gy of X-ray) of 8- to 10-week old male C57BL/6 mice 4 - 5 hrs before cell injection.
- Put the irradiated mouse into a restrainer to restrict its activity.
- Wipe the tail using a cotton swab steeped in 75% alcohol to promote vasodilatation of the vein.
- Inject 0.5 embryo equivalent (ee) or 1 ee single cell-suspensions of AGM intravenously into the tail vein of an irradiated mouse with a 1.0 cc syringe. AGM are injected at a dose of 1 ee per recipient with 2×105 bone marrow cells (CD45.1 background).
NOTE: No air can be introduced into the syringe. Press the injection site with an antiseptic swab to stop bleeding.
- Four months post-transplantation, collect the bone marrow of the recipient and use it for the reconstitution assay by FACS. Only the recipients with ≥10% donor-derived chimerism are considered to exhibit successful reconstitution.
A recent publication reported endothelial cell-derived serotonin promotes the survival of HSCs by inhibiting the pro-apoptotic pathway in the AGM13. To confirm the promoting effect of serotonin on HSC development, Fluoxetine was included. As a selective serotonin re-uptake inhibitor (SSRI), Fluoxetine has been demonstrated to inhibit serotonin re-absorption in peripheral tissues16,17,18. Using the AGM explant culture system, the effect of Fluoxetine on HSC development was examined by following the procedure presented above. The expression analyses showed increased expression of Runx1, which is defined as a pivotal gene for HSC development19, in Fluoxetine-treated AGMs at mRNA and protein levels, respectively (Figure 2A and 2B). Fluoxetine can also significantly increase the colony formation ability of HSCs in the AGM, including BFU-E, CFU-GM, and CFU-GEMM (Figure 2C and Figure 2D). In addition, in vivo transplantation results showed that HSCs in the AGM treated with Fluoxetine can increase the number of spleen colonies in irradiated adult recipients (Figure 2E).
Figure 1. Schematic representation of AGM structure and explant culture system.
(A) The flow chart for using the AGM explant culture systemto examine the effect of chemicals on HSCs development. Briefly, AGMs are dissected from embryos and cultured on filters at the air-liquid interface with chemicals diluted in M5300 long-term culture medium. 2 - 3 days later, the cultured AGMs are collected and used to examine the expression of hematopoietic related genes, colony formation ability, and repopulation capacity. AGM, aorta-gonad-mesonephros; CFU-C, colony-forming units in the culture; CFU-S, colony-forming units-spleen. (B) The structure of AGM is shown in this diagram. A, dorsal aorta; Me, mesenchyme; G, gonad; M, mesonephros. (C) The morphology of AGM. The AGM is separated from the caudal half of the embryonic body with the surrounding mesenchymal cells at E10.5. Scale bars = 1 mm. Please click here to view a larger version of this figure.
Figure 2. Application of the AGM explant culture system to detect the effect of Fluoxetine on HSC development. (A) The mRNA level of Runx1 in the AGMs treated with Fluoxetine at 10 µM was detected by quantitative real-time PCR. Student's t test: **, P<0.01. The results are presented as mean ± SEM. (B) Western blotting analysis further confirmed the increased expression of Runx1 at the protein level in the AGMs treated with Fluoxetine. (C) The representative images show the morphology of BFU-E, CFU-GM and CFU-GEMM. Scale Bars = 100 µm. (D) CFU-C assay showed that Fluoxetine treatment can increase the number of each type of colony. One embryo equivalent (ee) was used. Student's t test: *, P<0.05; **, P<0.01.The results are presented as mean ± SEM. (E) CFU-S assay with AGMs treated with Fluoxetine showed that Fluoxetine can increase the number of colonies in the spleen of irradiated adult recipients. Scale bars = 1.5 mm. 1 ee was used. Please click here to view a larger version of this figure.
It is well known that mature HSCs in the bone marrow can repopulate the blood system of irradiated recipients. Unlike these functional HSCs, the emerging HSCs in the AGM of mouse embryos are immature. Direct transplantation results showed that type I (VE-cad+ CD45- CD41+) and type II (VE-cad+ CD45+) pre-HSCs possess no reconstitution ability20. Taking advantage of the AGM explant culture system, the nascent HSCs in the AGM region can reconstitute the recipients in the transplantation assay4,20. Furthermore, due to the intrauterine development of the mouse embryo, in vivo experiments to rescue the impaired hematopoiesis in KO mice are inconvenient to perform. The AGM explant culture is an alternative system, which is well suited for rescue experiments, simply by adding the chemicals (growth factors and cytokines) into the medium13,15. In addition to the AGM, the yolk sac and fetal liver can also be cultured with this system7.
At the beginning of this experiment, the strict sterilization of filters and stainless steel meshes is quite important to avoid contamination. More importantly, the critical step in the culture is to make the dissected AGM cultured on the filters at the air-liquid interface. Too much medium will cause the AGM to be cultured in the liquid and it may be decayed, whereas too little medium will make the AGM dry. During culturing, maintaining the proper humidity of the cell incubator is also important to prevent the evaporation of the medium.
Further improvement of this explant culture system to truly mimic the development of HSCs in vivo, together with recent advancements in organoid culture techniques21, will greatly expand its application in hematopoiesis studies, from HSC self-renewal, multi-lineage differentiation, and HSC-niche interaction to disease modeling and drug discovery.
The authors have no conflicting financial interests.
We thank Suwei Gao for help in figure preparation. This work was supported by grants from the National Natural Science Foundation of China (81530004, 31425016) and the Ministry of Science and Technology of China (2016YFA0100500). J.L. performed the experiments and drafted the manuscript; F.L. edited the manuscript. Both authors read and approved the final manuscript.
|durapore 0.65 µm filters||Millipore||R5BA63787||AGM explant culture|
|M5300 long-term culture medium||Stem Cell Technologies||5300||AGM explant culture|
|M-MLV reverse transcriptase||Promega||90694||reverse transcription|
|SYBR Green||Qiagen||A6002||quantatitive real-time PCR|
|protease inhibitor||Roche||55622||Protein extration|
|collagenase||Sigma||C2674||digestion of AGM tissues|
|MethoCult GF M3434 medium||Stem Cell Technologies||3434||CFU-C assay|
|ultra-low attachment 24-well plates||Costar||3473||CFU-C assay|
|C57BL/6 CD45.2 mice||Beijing HFK Bioscience Co. Ltd||CFU-S assay|
|C57BL/6 CD45.1 mice||Beijing HFK Bioscience Co. Ltd||Long-term transplantation|
|phosphate buffered saline||Life Technologines||8115284||AGM Collection|
|Penicillin-Streptomycin solution||HyClone||SV30010||AGM explant culture|
|UV lamp||Beijing jiangmorning yuan bio-technology co., LTD||039-14402||power: 30W|
|stainless steel mesh||AS ONE SHANGHAI Corporation||2-9817-10||aperture diameter: 2.5 mm|
|hydrocortisone||Sigma||H0396||selectively diluted into M5300 medium|
- Bertrand, J. Y., et al. Haematopoietic stem cells derive directly from aortic endothelium during development. Nature. 464, 108-111 (2010).
- Boisset, J. C., Robin, C. Imaging the founder of adult hematopoiesis in the mouse embryo aorta. Cell cycle. 9, 2489-2490 (2010).
- Kissa, K., Herbomel, P. Blood stem cells emerge from aortic endothelium by a novel type of cell transition. Nature. 464, 112-115 (2010).
- Zovein, A. C., et al. Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell. 3, 625-636 (2008).
- Kumaravelu, P., et al. Quantitative developmental anatomy of definitive haematopoietic stem cells long-term repopulating units (HSC/RUs): role of the aorta-gonad-mesonephros (AGM) region and the yolk sac in colonisation of the mouse embryonic liver. Development. 129, 4891-4899 (2002).
- Orkin, S. H., Zon, L. I. Hematopoiesis: an evolving paradigm for stem cell biology. Cell. 132, 631-644 (2008).
- Medvinsky, A., Dzierzak, E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell. 86, 897-906 (1996).
- Peeters, M., et al. Ventral embryonic tissues and Hedgehog proteins induce early AGM hematopoietic stem cell development. Development. 136, 2613-2621 (2009).
- Taoudi, S., Medvinsky, A. Functional identification of the hematopoietic stem cell niche in the ventral domain of the embryonic dorsal aorta. PNAS. 104, 9399-9403 (2007).
- Crisan, M., et al. BMP and Hedgehog Regulate Distinct AGM Hematopoietic Stem Cells Ex Vivo. Stem Cell Reports. 6, 383-395 (2016).
- Durand, C., et al. Embryonic stromal clones reveal developmental regulators of definitive hematopoietic stem cells. PNAS. 104, 20838-20843 (2007).
- Fleury, M., Petit-Cocault, L., Clay, D., Souyri, M. Mpl receptor defect leads to earlier appearance of hematopoietic cells/hematopoietic stem cells in the Aorta-Gonad-Mesonephros region, with increased apoptosis. Int J Dev Biol. 54, 1067-1074 (2010).
- Lv, J., Wang, L., Gao, Y., Ding, Y. Q., Liu, F. 5-hydroxytryptamine synthesized in the aorta-gonad-mesonephros regulates hematopoietic stem and progenitor cell survival. J Exp Med. 214, 529-545 (2017).
- Souilhol, C., et al. Inductive interactions mediated by interplay of asymmetric signalling underlie development of adult haematopoietic stem cells. Nature communications. 7, 10784 (2016).
- Fitch, S. R., et al. Signaling from the sympathetic nervous system regulates hematopoietic stem cell emergence during embryogenesis. Cell Stem Cell. 11, 554-566 (2012).
- Bianchi, M., Moser, C., Lazzarini, C., Vecchiato, E., Crespi, F. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes. Exp Brain Res. 143, 191-197 (2002).
- Ortiz, J., Artigas, F. Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine. Br J Pharmacol. 105, 941-946 (1992).
- Wong, D. T., Horng, J. S., Bymaster, F. P., Hauser, K. L., Molloy, B. B. A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. Life sciences. 15, 471-479 (1974).
- Chen, M. J., Yokomizo, T., Zeigler, B. M., Dzierzak, E., Speck, N. A. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature. 457, 887-891 (2009).
- Rybtsov, S., et al. Hierarchical organization and early hematopoietic specification of the developing HSC lineage in the AGM region. J Exp Med. 208, 1305-1315 (2011).
- Muthuswamy, S. K. Bringing together the organoid field: from early beginnings to the road ahead. Development. 144, 963-967 (2017).